| Literature DB >> 35502419 |
Guanyu Zhang1,2, Jinghong Ma3, Piu Chan4, Zheng Ye5.
Abstract
Semantic fluency is the ability to name items from a given category within a limited time, which relies on semantic memory, working memory, and executive function. Semantic disfluency is a common problem in Parkinson's disease (PD) and Alzheimer's disease (AD). We demonstrated a graph theoretical analysis of semantic fluency in patients with PD (N = 86), patients with AD (N = 40), and healthy controls (HC, N = 88). All participants completed a standard animal fluency test. Their verbal responses were recorded, transcripted, and transformed into directed speech graphs. Patients with PD generated fewer correct words than HC and more correct words than patients with AD. Patients with PD showed higher density, shorter diameter, and shorter average shortest path length than HC, but lower density, longer diameter, and longer average shortest path length than patients with AD. It suggests that patients with PD produced relatively smaller and denser speech graphs. Moreover, in PD, the densities of speech graphs correlated with the severity of non-motor symptoms, but not the severity of motor symptoms. The graph theoretical analysis revealed new features of semantic disfluency in patients with PD.Entities:
Mesh:
Year: 2022 PMID: 35502419 PMCID: PMC9056264 DOI: 10.1155/2022/6935263
Source DB: PubMed Journal: Behav Neurol ISSN: 0953-4180 Impact factor: 3.112
Figure 1(a) Directed speech graphs of three representative participants. HC004, a healthy control subject; PD021, a patient with Parkinson's disease; AD663, a patient with Alzheimer's disease. (b) Graph geodesic as the shortest path (green) between two nodes (blue) in the three participants.
Demographic and clinical features, and neuropsychological measures of PD patients and healthy controls (means, standard deviations, and group differences).
| Features/measures | PD patients | Healthy controls | Group differences ( |
|---|---|---|---|
| Female: Male | 44 : 42 | 46 : 42 | 0.884 |
| Age (years) | 59.0 (9.5) | 58.1 (7.0) | 0.484 |
| Education (years) | 12.4 (3.2) | 12.9 (2.4) | 0.204 |
| Montreal cognitive assessment | 25.6 (2.4) | 27.9 (1.4) | <0.001∗ |
| Levodopa equivalent daily dose (mg) | 243.3 (248.6) | — | — |
|
| |||
| Hoehn and Yahr scale | 1.4 (0.5) | — | — |
| MDS-UPDRS III: Motor examination | 21.8 (12.6) | — | — |
| Disease duration (years) | 1.6 (2.2) | — | — |
| Duration of motor symptoms (years) | 2.8 (2.4) | — | — |
|
| |||
| MDS-UPDRS I: Non-motor experiences of daily living | 5.3 (4.0) | — | — |
| Beck depression inventory-II | 2.7 (2.0) | 2.1 (1.7) | 0.039 |
| REM sleep behavior disorder screening questionnaire | 3.7 (2.0) | 1.9 (1.8) | <0.001∗ |
| Epworth sleep scale | 3.1 (3.2) | 3.2 (2.3) | 0.820 |
Note: MDS-UPDRS, the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale; group differences, p values of two-sample t-tests, or Chi-square test as appropriate; asterisks (∗), a significant difference (two-tailed, p < 0.007 Bonferroni correction for seven tests).
Figure 2(a) Means and standard errors of correct words, repetitions, incorrect words, metalinguistic reference, and metacognitive reference in healthy controls (HC), patients with Parkinson's disease (PD), and patients with Alzheimer's disease (AD). (b) Means and standard errors of graph density, diameter, and average shortest path in each group. The asterisks (∗) indicate significant differences between PD patients and two control groups in standard and graph parameters. (c) In patients with PD, the density of speech graphs was correlated with the severity of non-motor symptoms (MDS-UPDRS I score) but not the severity of motor symptoms (MDS-UPDRS III score). Values were demeaned.